Track 15: Colorectal Cancer 13th International Cancer and Medical Oncology Conference and Exhibition
February 1–2, 2027 | Novotel Al Barsha, Dubai, UAE
Colorectal cancer remains one of the most prevalent and challenging malignancies worldwide, affecting millions of individuals each year. Advances in early detection, precision medicine, minimally invasive surgery, targeted therapy, immunotherapy, and molecular diagnostics are transforming the management of colorectal cancer and improving patient survival outcomes. Track 15: Colorectal Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition will provide a comprehensive scientific platform for discussing the latest breakthroughs, research discoveries, clinical trials, and multidisciplinary approaches in colorectal cancer care.
Hosted at the prestigious Novotel Al Barsha Dubai, this global oncology gathering will unite oncologists, surgeons, gastroenterologists, researchers, pathologists, radiologists, pharmaceutical experts, academicians, and healthcare professionals from around the world to exchange innovative ideas and promote collaborative research in gastrointestinal oncology.
Importance of Colorectal Cancer Research
Colorectal cancer is among the leading causes of cancer-related deaths globally. Increasing incidence rates, lifestyle-related risk factors, hereditary syndromes, and late-stage diagnosis continue to present major healthcare challenges. Modern oncology is now focusing on:
Survivorship and quality-of-life improvements
Track 15 will highlight these transformative developments while encouraging evidence-based discussions and translational research collaborations.
Key Topics Covered in Track 15
Benefits of Attending Track 15
Gain Latest Scientific Knowledge
Participants will learn about cutting-edge colorectal cancer research, emerging therapies, and innovative diagnostic technologies from internationally recognized experts.
Networking Opportunities
The conference provides a valuable platform to connect with oncologists, surgeons, researchers, healthcare institutions, pharmaceutical companies, and academic professionals worldwide.
CME & CPD Accreditation
Attendees can earn approximately 30 CME/CPD credits that support professional development, clinical excellence, and continuing medical education requirements.
Research Presentation Opportunities
Researchers and clinicians can present oral talks, posters, case studies, and ongoing clinical trial findings to an international scientific audience.
Exposure to Emerging Technologies
Participants will explore advancements in AI-assisted pathology, precision medicine, molecular diagnostics, targeted drug delivery systems, and next-generation cancer therapeutics.
Multidisciplinary Learning
Track 15 promotes collaboration between medical oncologists, radiation oncologists, colorectal surgeons, gastroenterologists, radiologists, pathologists, nurses, and healthcare innovators.
About the Conference
The 13th International Cancer and Medical Oncology Conference and Exhibition is a premier international oncology event dedicated to advancing cancer research, medical innovation, clinical excellence, and global collaboration in oncology care. The conference focuses on modern therapeutic strategies, translational research, patient-centered treatment models, and evidence-based oncology practices.
Conference Highlights
Venue Information
The conference will be hosted at Novotel Al Barsha Dubai, a modern and well-connected venue located in the heart of Dubai. The hotel offers advanced conference facilities, luxury accommodations, international dining experiences, business amenities, and easy access to Dubai’s major attractions including Dubai Marina, Burj Khalifa, Mall of the Emirates, and Jumeirah Beach.
Dubai serves as a global hub for innovation, healthcare, business, and tourism, making it an ideal destination for international scientific conferences and medical networking.
CME & CPD Accreditation
The conference emphasizes continuing medical education and professional excellence through accredited educational activities. Participants attending Track 15 can benefit from:
Continuing Medical Education plays a crucial role in improving clinical competency, patient outcomes, and adoption of advanced oncology practices.
Who Should Attend?
Medical Oncologists
Surgical Oncologists
Gastroenterologists
Additional Information
Registration
Participants can register through the official conference registration portal. Early bird registrations, speaker registrations, virtual participation, and student categories are available.
Exhibition & Sponsorship
The conference offers international exhibition and sponsorship opportunities for healthcare companies, biotech firms, pharmaceutical organizations, medical device manufacturers, and research institutions.
Abstract Submission
Researchers are invited to submit abstracts for oral presentations, posters, workshops, and case discussions related to colorectal cancer and oncology innovations.
Conclusion
Track 15: Colorectal Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition will serve as a dynamic global platform for discussing innovative colorectal cancer research, clinical advancements, and multidisciplinary treatment strategies. By bringing together world-renowned oncology experts, researchers, healthcare professionals, and industry leaders, this conference aims to strengthen scientific collaboration and accelerate progress in colorectal cancer diagnosis, prevention, treatment, and survivorship care.
Attendees will gain valuable scientific insights, international networking opportunities, CME/CPD accreditation, and exposure to cutting-edge oncology technologies that will help shape the future of colorectal cancer management worldwide.
Important Links
https://cancer.utilitarianconferences.com/
https://cancer.utilitarianconferences.com/registration
https://cancer.utilitarianconferences.com/submit-abstract
.jpg)
Comments
Post a Comment